Literature DB >> 28323776

The Authors' Reply.

Mepur H Ravindranath1, Vadim Jucaud.   

Abstract

Year:  2017        PMID： 28323776      PMCID： PMC7228573          DOI： 10.1097/TP.0000000000001629

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  13 in total

Review 1.  Open conformers: the hidden face of MHC-I molecules.

Authors:  Fernando A Arosa; Susana G Santos; Simon J Powis
Journal:  Trends Immunol       Date:  2007-01-29       Impact factor: 16.687

2.  Expression of beta 2-microglobulin-free HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers.

Authors:  W F Pickl; W Holter; J Stöckl; O Majdic; W Knapp
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

3.  Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions.

Authors:  Vadim Jucaud; Mepur H Ravindranath; Paul I Terasaki
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

4.  Conformational Variants of HLA-I Antigens on Luminex Single Antigen Beads.

Authors:  Jonathan Visentin; Gwendaline Guidicelli; Jean-Luc Taupin
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

5.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

Authors:  N J Stam; H Spits; H L Ploegh
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

6.  Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation.

Authors:  Jonathan Visentin; Mélanie Marroc; Gwendaline Guidicelli; Thomas Bachelet; Thoa Nong; Jean-François Moreau; Jar-How Lee; Pierre Merville; Lionel Couzi; Jean-Luc Taupin
Journal:  Clin Transplant       Date:  2015-03-13       Impact factor: 2.863

Review 7.  Anti-HLA-E monoclonal antibodies reacting with HLA-la and lb alleles like IVIg as potential IVIg-immunomimetics: an evolving therapeutic concept.

Authors:  Mepur H Ravindranath; Dong Zhu; Tho Pham; Vadim Jucaud; Judy Hopfield; Satoru Kawakita; Paul I Terasaki
Journal:  Clin Transpl       Date:  2013

8.  Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection.

Authors:  Junchao Cai; Paul I Terasaki; Dong Zhu; Nils Lachmann; Constanze Schönemann; Matthew J Everly; Xin Qing
Journal:  Exp Mol Pathol       Date:  2015-11-23       Impact factor: 3.362

9.  Many de novo donor-specific antibodies recognize β2 -microglobulin-free, but not intact HLA heterodimers.

Authors:  K Michel; R Santella; J Steers; A Sahajpal; F X Downey; V Thohan; M Oaks
Journal:  HLA       Date:  2016-04-06       Impact factor: 4.513

Review 10.  Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors.

Authors:  Rachel L Allen; John Trowsdale
Journal:  Curr Mol Med       Date:  2004-02       Impact factor: 2.222
View more
  2 in total

1.  Monitoring native HLA-I trimer specific antibodies in Luminex multiplex single antigen bead assay: Evaluation of beadsets from different manufacturers.

Authors:  Mepur H Ravindranath; Vadim Jucaud; Soldano Ferrone
Journal:  J Immunol Methods       Date:  2017-08-04       Impact factor: 2.303

Review 2.  Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Edward J Filippone
Journal:  Vaccines (Basel)       Date:  2021-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.